Publications

Dolutegravir as first- or second-line treatment for children living with HIV: 240-week follow-up of the ODYSSEY randomised trial

2026

Authors: Mujuru HA, White E, Kekitiinwa AR, Lugemwa A, Kityo C, Violari A, Ahimbisibwe GM, Variava E, Archary M, Cotton M, Ounchanum P, Puthanakit T, Kanjanavanit S, Ngampiyaskul C, Kobbe R, Bandi S, Epaiza C, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Kaudha E, Cressey TR, Giaquinto C, Jafta L, Bamford A, Rojo P, Gibb DM, Turkova A, Ford D, on behalf of the ODYSSEY Trial Team

Published inOpen Forum Infectious Diseases

Mpox in Children and Adolescents

2026

Authors: Aguilera-Alonso D, Sam-Agudu NA, Muhindo-Mavoko H, Pana ZD.

Published in: The Pediatric Infectious Disease Journal

Kangaroo Care as an intervention in randomised controlled trials in neonatal intensive care

2026

Authors: Minotti C, Wallis L, Hoesli J, Schlaeppi C, Nyantakyi E, Schultes MT, Jost K, Bielicki JA.

Published in: Pediatric Research

Risk factors for antibiotic-resistant bacterial colonisation in European Neonatal Units

2026

Authors: Cook A, Berkell M, van Werkhoven H, Sieswerda E, Smith DRM, Minotti C, van Heirstraeten L, Malhotra-Kumar S, Bielicki JA; on behalf of the NeoIPC Consortium

Presented at: Pediatric Academic Societies (PAS) Meeting

High engagement and positive satisfaction of healthcare workers about an online training for infection prevention and control and antimicrobial stewardship (the TEAM-COACH project)

2026

Authors: Epalza C, Brigadoi G, Goycochea W, Kopsidas I, Villaverde S, Barbieri E, Bason M, Kousi D, Arias A, Aboza M, Tsopela GC, Donà D, Neth O, Cantarutti L, Gianquinto C, Gâchet A, Gastesi I, Amores M, Rojo P, and the TEAM-COACH Working Group.

Presented at: ESCMID Global 2026 (Poster #P3018)

Clinical practice indicators in infection prevention/control and antimicrobial stewardship in the paediatric population before and after the participation in an online educational project (the TEAM-COACH project)

2026

Authors: Epalza C, Brigadoi G, Goycochea W, Kopsidas I, Villaverde S, Barbieri E, Bason M, Kousi D, Arias A, Aboza M, Tsopela GC, Donà D, Neth O, Cantarutti L, Gianquinto C, Gâchet A, Gastesi I, Amores M, Rojo P, and the TEAM-COACH Working Group.

Presented at: ESCMID Global 2026 (Poster #P3022)

Digital Training for IPC and AMS in Paediatric Inpatient Units: Multicountry Implementation and Outcomes From the TEAM-COACH Project

2026

Authors: Kopsidas I, Goycochea W, Brigadoi G, Villaverde S, Barbieri E, Bason M, Kousi D, Aboza M, Donà D, Tsopela GC, Neth O, Arias A, Cantarutti L, Gianquinto C, Gâchet A, Gastesi I, Amores M, Rojo P, Epalza C, and the TEAM-COACH Working Group.

Presented at: ESCMID Global 2026 (Poster #P3024)

Impact in capacity building of an online training program and evaluation of factors related to behavioural change in infection prevention and control and antimicrobial stewardship practices (the TEAM-COACH project)

2026

Authors: Goycochea‑Valdivia W, Gâchet A, Amores M, Kopsidas I, Brigadoi G, Barbieri E, Bason M, Kousi D, Aboza M, Villaverde S, Donà D, Tsopela GC, Neth O, Arias A, Cantarutti L, Gianquinto C, Gastesi I, Rojo P, Epalza C, and the TEAM‑COACH Working Group.

Presented at: ESCMID Global 2026 (Presentation #O6993)

The association between colonisation pressure and acquisition of ESBL bacterial gut colonisation on the neonatal unit: findings from the NeoIPC colonisation assessment

2026

Authors: Cook A, Berkell M, van Werkhoven H, Sieswerda E, Smith DRM, Minotti C, van Heirstraeten L, Malhotra-Kumar S, Bielicki JA; on behalf of the NeoIPC Consortium.

Presented at: ESCMID Global 2026 (ePoster #E0464)

High rates of Candida colonisation in European neonates: a sub-analysis of the NeoVanc randomised controlled trial

2026

Authors: Hill LF, Shahed F, Fermin Luque J, Monahan I, Planche T, Clements MN, Ferreras Antolín L, Turner MA, Lutsar I, Roilides E, Sharland M, Lindsay JA, Heath PT, NeoVanc Consortium.

Presented at: ESCMID Global 2026 (ePoster #E0881)

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial

2026

Authors: Jacobs TG, Mumbiro V, Tembo J, Egbe FN, Moraleda C, dos Anjos Botas Becah LS, Passandu A, Kakooza L, Chitsamatanga M, Ndunaku B, Bramugy J, Tagarro A, Chhaganlal KD, Mutesi S, Mark NL, Bwakura-Dangarembizi M, Namuzizya N, Ballesteros A, Dominguez-Rodríguez S, Colbers A, Sacarlal J, Nalwanga D, Mujuru HA, Chabala C, Madrid L, Bucki WC, Musiime V, Bates M, Rojo P, Burger DM; EMPIRICAL Clinical Trial Group.

Published in: EClinical Medicine

A Call for international collaboration to improve definitions for the surveillance of congenital syphilis

2026

Authors: Foley DJ, Gwee A, Epalza C, Marks M, Vidal Castro J, Tzaki A, Barroso Hofer C, Bamford A, Frigati L, Lishman J, Harrison M, Williams PCM, Mårdh O, Freyne B; Prevent Syphilis Network/Penta ID Network Collaboration

Published in: Pediatric Infectious Disease Journal

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial

2026

Authors: Wyncoll J, Kamolrattana R, Archary M, Mujuru HA, Kekitiinwa AR, Violari A, Na-Rajsima S, Lugemwa A, Variava E, Cotton M, Kityo CM, Königs C, Behuhuma NO, Welch S, Saïdi Y, Marques L, Ahimbisibwe GM, Houlden L, Giaquinto C, Rojo P, Gibb DM, Puthanakit T, Turkova A, White E, Ford D, ODYSSEY Trial Team

Published inClinical Infectious Diseases

Evaluating COVID-19 vaccine allocation policies using Bayesian m-top exploration

2026

Authors: Cimpean A, Verstraeten T, Willem L, Hens N, Nowé A, Libin P.

Published in: Nature Scientific Reports

Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review

2026

Authors: O’Rourke J, Townsend CL, Milanzi E, Castro H, Collins IJ, Judd A, Jesson J, Leroy V, Penazzato M, Vicari M, Renaud F

Published in: BMC Infectious Diseases

Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial

2026

Authors: Kekitiinwa AR, Meda M, Jennings A, Bwakura-Dangarembizi M, Kityo C, Siika A, Archary M, Green A, Jafta L, Akabwai GP, Mujuru HA, Mugerwa H, Kiilu C, Mngqibisa R, Seeley J, Nazzinda R, Apoto N, Walker S, Burger D, Giaquinto C, Okello RB, Musoro G, Wambui C, Arumugam T, Conway M, Van Looy N, South A, Bamford A, Thomason MJ, Ford D, Pett SL, on behalf of the BREATHER Plus Trial Team

Published in: The Lancet HIV

Tracing the threads: a system dynamics and network diffusion model of kangaroo care implementation in neonatal care

2026

Authors: Nyantakyi E, Block P, Clack L, Schultes M-T.

Published in: Implementation Science Communications

Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice

2026

Authors: Gobat N, Slack C, Hannah S, Salzwedel J, Bladon G, Burgos JG, Purvis B, Molony-Oates B, Siegfried N, Cheah PY, Conway M, Kamuya D, Davies A, Johnson T, Tholanah M, Mugamba S, Mutengu NL, Machingaidze S, Schwartz L, Rägo L, von Harbou K.

Published in: The Lancet Global Health

Risk of SARS-CoV-2 Infection and Hospitalisation in Immunocompromised Children: A Population-Based Cohort Study in Italy and Norway

2026

Authors: Di Chiara C, Boracchini R, Trinh NTH, Giugni A, Sturniolo G, Visonà E, Judd A, Le Prevost M, Thorne C, Hardelid P, Giaquinto C, Lupattelli A, Donà D, Cantarutti A.

Published in: Acta Paediatrica

DTG/3TC is non-inferior to DTG-based 3-drug ART in children with HIV: D3/Penta 21 week-96 results

2026

Authors: Turkova A, Chan MK, Kekitiinwa AR, Mutuluuza CK, Musoke P, Cressey TR, Violari A, Archary M, Variava E, Rojo P, Welch SB, Thomason MJ, Giaquinto C, Ford D.

Presented at: CROI 2026

Proactive vs. reactive COVID-19 screening in schools: Lessons from experimental protocols in France during the Delta and Omicron waves

2026

Authors: Colosi E, Lina B, Elias C, Vanhems P, Colizza V.

Published in: PNAS Nexus

Empirical treatment against cytomegalovirus and tuberculosis in severe pneumonia in HIV-infected infants: a randomized controlled clinical trial

2026

Authors: Moraleda C, Rojo P, Dominguez S, Dominguez S, Buck CW, Musiime V, Mujuru HA, Chabala C, Mvalo T, Bramugy J, Madrid L, Sacarlal J, Ghambi L, Fernandez-Luis S, Bates M, Tagarro A.

Presented at: CROI 2026

Sex matters: A Bayesian approach to analyzing sex differences in an African pediatric cohort

2026

Authors: Gastesi Orbegozo I, Ballesteros A, Barnabas S, Barnabas S, Behuhuma O, Lain MG, Nhampossa T, Otwombe K, Rossi P, Giaquinto C, Kuhn L, Reddy K, Cotugno N, Rojo P, Tagarro A, Dominguez-Rodriguez S; on behalf of the EPIICAL consortium.

Presented at: CROI 2026

Prime-boost HIVIS DNA and MVA-CMDR regimen induces robust Env and Gag antibody responses in youth living with HIV

2026

Authors: Kim J, Slike B, McCarragher C, Nguyen P, Metzger L, Moreland S, Pinyakorn S, Schluck G, Krebs S, Rao M, Palma P, Robb M; on behalf of the RV534 study group.M, Cotugno N, Maldarelli F, Palma P, Spiegel H, Robb M, Persaud D; on behalf of the RV534 Study Group.

Presented at: CROI 2026

HIV-1 DNA dynamics with HIVIS DNA/MVA-CDMR vaccinations +/-TLR4 Agonist: the HVRRICANE trial

2026

Authors: Dhummakupt A, Szewczyk J, Barnabas S, Cotton M, Gorelick R, Pinyakorn S, Turk E, DeSouza M, Cotugno N, Maldarelli F, Palma P, Spiegel H, Robb M, Persaud D; on behalf of the RV534 Study Group.

Presented at: CROI 2026

Pharmacokinetics of a Novel Dose Ratio of DTG/FTC/TAF for African Children with HIV (UNIVERSAL1)

2026

Authors: Kamphuis AEM, Mujuru HA, Bwakura-Dangarembizi MF, Kisitu GP, Matovu F, Kaudha E, Mulindwa A, Jacobs TG, Salvadori N, Than-in-at K, Cressey TR, Nardone A, Lallemant M, Burger DM, for the UNIVERSAL1 Trial Team.

Presented at: CROI 2026

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance

2026

Authors: Grasa C, Salvadori N, Nardone A, Than-in-at K, Koblansky A, Parry C, Thakkar N, Wang M, Giaquinto C, Rojo P & Cressey RT

Published in: BMC Infectious Diseases

Paediatric infection hospital admissions in England before, during and after the COVID-19 pandemic

2026

Authors: Jackson C, Wijlaars L, Abdullahi F, Liu M, Judd A, Thorne C, Collins IJ, Di Chiara C, Hardelid P.

Published in: Epidemiology and Infection

Implementation of optimized kangaroo care for infection prevention and control in neonatal intensive care units (NeoIPC): Protocol for the implementation elements of a multicenter parallel cluster randomized hybrid type 2 implementation-effectiveness study

2026

Authors: Schultes MT, Baenziger J, Nyantakyi E, Wu CX, Ferrari G, Sieswerda E, van Werkhoven CH, Minotti C, Wolfensberger A, Tediosi F, D’Ambrosio F, Bielicki JA, Clack L, and the NeoIPC Consortium.

Published in: Implementation Science

Methodological framework for the surveillance of healthcare-associated infections in high-risk infants: the NeoIPC surveillance core module protocol

2026

Authors: Karadağ G, Bekker A, Dramowski A, Loureiro Gonzalez B, Pérez López J, Pijoan Zubizarreta JI, Heath PT, Aghdassi SJS, Piening B.

Published in: Antimicrobial Resistance & Infection Control

Recurrent wheezing as a mediator between early-life exposures and childhood asthma: a mediation analysis in an Italian primary care paediatric cohort

2026

Authors: Boracchini R, Canova C, Bendoni S, Di Chiara C, Giaquinto C, Baraldi E, Cantarutti A.

Published in: BMJ Public Health

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy

2026

Authors: Sconza R, Taylor GP, Ene L, Kahlert C, van der Wekken-Pas L, Renaud F, Thorne C, Townsend CL.

Published in: AIDS

Intentions and attitudes of caregivers towards enrolment of their children and adolescents living with HIV into remission trials involving analytic treatment interruption

2026

Authors: Peay HL, Otwombe K, Barnabas S, Barrios-Tascon A, Lain MG, Nhampossa T, Rutebarika D, Jupimai T, Archary M, Maiga A-I, Violari A, Spyer MJ, Reddy K, Palma P, Pahwa S, Lichterfeld M, Cotton M, Kuhn L.

Published in: Journal of the International AIDS Society

Integrating life course perspectives into research involving people living with perinatally acquired HIV

2026

Authors: Toledo G, Le Prevost M, Judd A, Collins IJ.

Published in: BMC Global and Public Health

Perinatal HIV exposure is associated with long-term alterations in immune marker levels in children

2026

Authors: Avendaño-Ortiz J, Ventosa-Cubillo J, Rodríguez-Jiménez C, Morales-Pérez D, Muñoz-Hernández R, Pavía-Ruz N, Navarro ML, Holguín Á.

Published in: Journal of Infection and Public Health

Changes in pediatric primary care contacts: has the RSV-immunization modified the age-related access?

2026

Authors: Boracchini R, Barbieri E, Canova B, Baraldi E, Giaquinto C, Cantarutti A.

Published in: Italian Journal of Pediatrics

The evolving landscape of RSV immunization: Current policies and practices across Europe

2026

Authors: Franck Z, Hofstraat S, Jonker L, Kragten L, Messina C, Fernandes MR, Bruijning-Verhagen P, PIPELINE National Coordinators

Published in: Vaccine

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience

2026

Authors: Dehghan Tarazjani A, Weibel D, Aurelius T, Zwiers LC, Van den Berg JM, Pérez-Breva L, Gimeno-Miguel A, Stona L, Solórzano M, Desalegn AA, Poblador-Plou B, Lysen TS, Wheler J, Zidan M, Carreras JJ, Villalobos F, Ehrenstein V, Morton K, Rebordosa C, Ahmadizar F, Fortuny J, Arana A, Sturkenboom M.

Published in: Clinical Epidemiology

Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial

2026

Authors: Turkova A, White E, Violari A, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kaudha E, Na-Rajsima S, Ahimbisibwe GM, Variavae E, Archary M, Akhalwaya Y, Puthanakit T, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Liberty A, Königs C, Welch SB, Riault Y, Bamford A, Cressey TR, Musoke P, Kityo C, Ferrand R, Giaquinto C, Rojo P, Gibb DM, Ford D; ODYSSEY trial team

Published in: The Lancet Child & Adolescent Health

Rapid Qualitative Approaches in Pandemic Research: Protocol for an Exploratory Qualitative Multimethod Study (VERDIQual) on Mpox in Italy, Nigeria, Thailand, and the United Kingdom

2026

Authors: Osa-Afiana C, Le Prevost M, Nicholls EJ, Bilardi D, Guadamuz TE, Soje-Amadosi EE, Adebisi GI, Adirieje C, Adetunji AA, Yusufu K, Witzel TC, Waratworawan W, Samoh N, May T, Denford S, Gomes W, Adirieje U, Tariq S, Sam-Agudu NA.

Published in: JMIR Research Protocols

Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling

2026

Authors: Di Domenico L, Bosetti P, Sabbatini CE, Opatowski L, Colizza V.

Published in: Nature Communications

Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

2026

Authors: Anena D, Chappell E, Nazzinda R, Kiilu C, Chitsamatanga M, Arumugam T, Green A, Mutuluuza CK, Bwakura-Dangarembizi M, Siika A, Archary M, Jafta L, Namukwaya S, Seeley J, Akabwai G, Mugerwa H, Bevers L, Burger D, Walker S, Bamford A, South A, Apoto N, Bush M, Thomason MJ, Spittle B, Ford D, Kekitiinwa AR, Pett SL; LATA Trial Team.

Published in: Contemporary Clinical Trials

Household SARS-CoV-2 transmission during Omicron wave in Chiang Mai, Thailand: a prospective observational study

2026

Authors: Khamduang W, Suebtam P, Collins IJ, Sripan P, Chalom K, Hongjaisee S, Kham-Kjing N, Wangsaeng N, Inmonthian P, Pinasu A, Kohklang N, Arnal M, Spyer M, Steffens-Westerhof I, Aramrattana A, Lallemant M, Angkurawaranon C, Bruijning-Verhagen P, Ngo-Giang-Huong N; Thailand VERDI-RECOVER Study Team.

Published in: The Lancet Regional Health – Southeast Asia

Associations between virus single or coinfections and respiratory symptoms in young children; a community-based cohort study

2025

Authors: Hauser-van Westrhenen E, Junquera Guinovart L, Schuurman R, van Boven M, Bonten M, Bruijning-Verhagen P.

Published in: International Journal of Infectious Diseases

Late diagnosis of paediatric HIV infection in high-income countries: Lessons from the HIV Perinatal Virtual Clinic

2025

Authors: Curto C, Tritzali M, Bamford A, Bailey AC, Lyall EGH, Mackie NE, Tickner N, Foster C; on behalf of the PVC.

Published in: HIV Medicine

Epidemiological characteristics of Monkeypox Virus Clade Ib in the Democratic Republic of Congo: the impact of transmission mode

2025

Authors: Kremer C, Nundu SS, Vakaniaki EH, Brosius I, Mukari G, Munganga P, Bangwen E, Mujula Y, De Vos E, Van Dijck C, Houben S, Gressani O, Kacita C, Mukadi-Bamuleka D, Muyembe-Tamfum JJ, Mbala-Kingebeni P, Liesenborghs L, Hens N, Torneri A.

Published in: Nature Communications

Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine

2025

Authors: Tagarro A, Gastesi I, Hotterbeekx A, Aguilera-Alonso D, Konnova A, Gupta A, Salso S, Berkell M, Plata MdC, Domínguez-Rodríguez S, Ballesteros Á, Manzanares Á, Oltra M, Villanueva S, Pinto C, Guillén R, Giaquinto C, Moraleda C, Kumar-Singh S.

Published in: Pediatric Infectious Disease Journal

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis

2025

Authors: Parkinson EC, Watkins WJ, Edkins S, McLaren JE, Clements MN, Andrews R, Liberatore F, Lutsar I, Turner MA, Roilides E, Heath PT, Sharland M, Hill LF, Ghazal P; on behalf of the NeoVanc Consortium.

Published in: Science Translational Medicine

BNT162b2 mRNA COVID-19 vaccine effectiveness in pregnancy: Emulating trial NCT04754594 using observational data from Norwegian health registries

2025

Authors: Zidan M, Trinh N, Desalegn A, Smith LH, van Gelder M, Nordeng H, Lupattelli A.

Published in: Vaccine

Risk factors for antibiotic resistant bacterial colonisation in European Neonatal Units – results of the NeoIPC feasibility study

2025

Authors: Minotti C, Cook A, Berkell M, Bielicki J, on behalf of the NeoIPC Consortium.

Presented at: jENS Congress 2025

1234567891011121314151617